ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Concept Of Four Contract Program

May 29, 1981

The Lancet Oncology Issues “Expression Of Concern” Over Paper

July 23, 2010

Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial

June 28, 2002

NCI Cooperative Group Clinical Trials Approved

May 29, 2009

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009